أيسلندا -
الأيسلاندية -
LYFJASTOFNUN (Icelandic Medicines Agency)
doxycyklin eql pharma tafla 100 mg
eql pharma ab - doxycyclinum inn - tafla - 100 mg
أيسلندا -
الأيسلاندية -
LYFJASTOFNUN (Icelandic Medicines Agency)
oracea hart hylki með breyttan losunarhraða 40 mg
galderma nordic ab - doxycyclinum inn - hart hylki með breyttan losunarhraða - 40 mg
أيسلندا -
الأيسلاندية -
LYFJASTOFNUN (Icelandic Medicines Agency)
doxylin tafla 100 mg
actavis group ptc ehf. - doxycyclinum inn - tafla - 100 mg
أيسلندا -
الأيسلاندية -
LYFJASTOFNUN (Icelandic Medicines Agency)
phenoleptil tafla 100 mg
dechra regulatory b.v. - phenobarbitalum inn - tafla - 100 mg
أيسلندا -
الأيسلاندية -
LYFJASTOFNUN (Icelandic Medicines Agency)
phenoleptil tafla 25 mg
dechra regulatory b.v. - phenobarbitalum inn - tafla - 25 mg
الاتحاد الأوروبي -
الأيسلاندية -
EMA (European Medicines Agency)
velphoro
vifor fresenius medical care renal pharma france - sucroferric oxyhydroxide - hyperphosphatemia; renal dialysis - lyf til meðferð kalíum og blóðfosfathækkun - velphoro er ætlað til að stjórna fosfórmagn í sermi hjá sjúklingum með langvarandi nýrnabilun hjá fullorðnum sjúklingum með blóðskilun (hd) eða kviðskilun (pd). velphoro is indicated for the control of serum phosphorus levels in paediatric patients 2 years of age and older with ckd stages 4-5 (defined by a glomerular filtration rate.
الاتحاد الأوروبي -
الأيسلاندية -
EMA (European Medicines Agency)
esbriet
roche registration gmbh - pirfenidone - idiopathic pulmonary fibrosis; lung diseases; respiratory tract diseases - Ónæmisbælandi lyf - esbriet is indicated in adults for the treatment of idiopathic pulmonary fibrosis.
الاتحاد الأوروبي -
الأيسلاندية -
EMA (European Medicines Agency)
isemid
ceva santé animale - gi - hár-loft þvagræsilyf, súlfónamíð, látlaus - hundar - fyrir meðferð klínískum merki tengjast hjartabilun í hunda, þar á meðal í lungum bjúg.
الاتحاد الأوروبي -
الأيسلاندية -
EMA (European Medicines Agency)
pirfenidone axunio (previously pirfenidone aet)
axunio pharma gmbh - pirfenidone - idiopathic lungvefi - Ónæmisbælandi lyf - pirfenidone aet is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).
الاتحاد الأوروبي -
الأيسلاندية -
EMA (European Medicines Agency)
pirfenidone viatris
viatris limited - pirfenidone - idiopathic pulmonary fibrosis; lung diseases; respiratory tract diseases - Ónæmisbælandi lyf - pirfenidone viatris is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).